A detailed history of Ameriprise Financial Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 38,107 shares of TRDA stock, worth $669,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,107
Previous 13,547 181.29%
Holding current value
$669,158
Previous $193,000 215.54%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.65 - $17.86 $335,244 - $438,641
24,560 Added 181.29%
38,107 $609,000
Q2 2024

Aug 14, 2024

BUY
$11.85 - $16.45 $160,531 - $222,848
13,547 New
13,547 $193,000

Others Institutions Holding TRDA

About Entrada Therapeutics, Inc.


  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $551M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.